InvestorsHub Logo
Followers 49
Posts 3257
Boards Moderated 0
Alias Born 10/28/2012

Re: Inoviorulez post# 119401

Friday, 11/06/2015 1:24:31 PM

Friday, November 06, 2015 1:24:31 PM

Post# of 130503
Correct "can be".

You wrote:

"1. Now they are thinking about spinning out Eltoprazine or ESS as a standalone company since each has 3 indications it could target."

Nowhere does it say AMBS is thinking about spinning it out themselves which is what you stated. Merely stating the could be there own companies or subsidiary under another company.